Continuous, low-dose therapy with interferon-alpha for human immunodeficiency virus (HIV)-related immune thrombocytopenic purpura.

Abstract

A patient with HIV-related immune thrombocytopenic purpura (HIV-ITP) had a rapid rise in platelet count when treated with interferon-alpha 2b, 3 million units three times weekly. There were no significant toxicities with therapy. His platelet count fell to pretreatment levels when therapy was discontinued, then increased again when therapy was reinstituted… (More)

Topics

Cite this paper

@article{Northfelt1991ContinuousLT, title={Continuous, low-dose therapy with interferon-alpha for human immunodeficiency virus (HIV)-related immune thrombocytopenic purpura.}, author={Donald W. Northfelt and Lawrence D. Kaplan and Donald I. Abrams}, journal={American journal of hematology}, year={1991}, volume={38 3}, pages={238-9} }